Value Transformation: Observations on the Second Annual Evaluation Report of the Oncology Care Model

Careful planning, improving access to care, and managing pain, depression and side effects are logical paths to better oncology care. Three Precision for Value experts—Larry Blandford, Executive Vice President, Managing Partner; Maureen Hennessey, Senior Vice President, Director of Value Transformation; and Linda Bolland, Senior Advisor, explain how in the Journal of Clinical Pathways.

To read the full article, click here

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.